Management of drug-resistant tuberculosis

C Lange, K Dheda, D Chesov, AM Mandalakas… - The Lancet, 2019 - thelancet.com
Drug-resistant tuberculosis is a major public health concern in many countries. Over the past
decade, the number of patients infected with Mycobacterium tuberculosis resistant to the …

Constructing care cascades for active tuberculosis: a strategy for program monitoring and identifying gaps in quality of care

R Subbaraman, RR Nathavitharana, KH Mayer… - PLoS …, 2019 - journals.plos.org
The cascade of care is a model for evaluating patient retention across sequential stages of
care required to achieve a successful treatment outcome. This approach was first used to …

Telemedicine as the new outpatient clinic gone digital: position paper from the pandemic health system REsilience PROGRAM (REPROGRAM) international …

S Bhaskar, S Bradley, VK Chattu, A Adisesh… - Frontiers in public …, 2020 - frontiersin.org
Technology has acted as a great enabler of patient continuity through remote consultation,
ongoing monitoring, and patient education using telephone and videoconferencing in the …

[HTML][HTML] Technologies for medication adherence monitoring and technology assessment criteria: narrative review

M Mason, Y Cho, J Rayo, Y Gong… - JMIR mHealth and …, 2022 - mhealth.jmir.org
Background Accurate measurement and monitoring of patient medication adherence is a
global challenge because of the absence of gold standard methods for adherence …

Factors influencing patient adherence to tuberculosis treatment in Ethiopia: a literature review

ZS Nezenega, L Perimal-Lewis, AJ Maeder - International journal of …, 2020 - mdpi.com
Background: Tuberculosis (TB) is a major global public health problem and one of the
leading causes of death among infectious diseases. Although TB can be cured with first-line …

Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies

IS Pradipta, D Houtsma, JFM van Boven… - NPJ primary care …, 2020 - nature.com
Non-adherence to anti-tuberculosis (anti-TB) medication is a major risk factor for poor
treatment outcomes. We therefore assessed the effectiveness of medication adherence …

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies

F Mahfoud, M Azizi, S Ewen, A Pathak… - European heart …, 2020 - academic.oup.com
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in
device-based hypertension therapies | European Heart Journal | Oxford Academic Skip to Main …

India's syndemic of tuberculosis and COVID-19

R Shrinivasan, S Rane, M Pai - BMJ global health, 2020 - gh.bmj.com
Before COVID-19 became a global pandemic, India was dealing with another, much older
epidemic—tuberculosis(TB)—which affected 2.64 million Indians in 2019 and killed nearly …

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials

A Vernon, K Fielding, R Savic, L Dodd, P Nahid - PLoS medicine, 2019 - journals.plos.org
The importance of adherence in tuberculosis treatment clinical trials and its relevance in
explanatory and pragmatic trials | PLOS Medicine Skip to main content Advertisement PLOS …

[HTML][HTML] Closing gaps in the tuberculosis care cascade: an action-oriented research agenda

R Subbaraman, T Jhaveri… - Journal of clinical …, 2020 - Elsevier
The care cascade—which evaluates outcomes across stages of patient engagement in a
health system—is an important framework for assessing quality of tuberculosis (TB) care. In …